Volume 12, Issue 8 e9129
CASE REPORT
Open Access

Isolated unilateral ptosis as a complication of sinusitis: A case report and literature review

Youssef El Sayed Ahmad

Corresponding Author

Youssef El Sayed Ahmad

Maryland ENT center, Baltimore, Maryland, USA

Medstar health, Baltimore, Maryland, USA

Sinai Hospital of Baltimore, Baltimore, Maryland, USA

Correspondence

Youssef El Sayed Ahmad, 2401 W Belvedere Ave, Baltimore, MD 21215, USA.

Email: [email protected]

Contribution: Conceptualization, Data curation, Formal analysis, Methodology, Writing - original draft

Search for more papers by this author
Mohammad Abraham Kazemizadeh Gol

Mohammad Abraham Kazemizadeh Gol

Maryland ENT center, Baltimore, Maryland, USA

Medstar health, Baltimore, Maryland, USA

Sinai Hospital of Baltimore, Baltimore, Maryland, USA

Contribution: Conceptualization, Funding acquisition, Methodology, Resources, Supervision, Validation, Writing - review & editing

Search for more papers by this author
First published: 06 August 2024

Abstract

Key Clinical Message

Ptosis associated with rhinosinusitis may indicate orbital or cavernous sinus involvement, typically accompanied by various other symptoms. However, isolated ptosis is a rare occurrence. This explains the diverse treatment approaches found in this literature review, ranging from conservative management to surgery. Imaging plays a crucial role in diagnosis and treatment planning.

Isolated upper lid ptosis is a rare manifestation of acute rhinosinusitis, typically occurring without other neuro-ophthalmological or orbital signs. This report presents a case of unilateral isolated ptosis in an adult male with acute rhinosinusitis. A 30-year-old male with asthma and bipolar disorder, and recent intranasal drug use, presented with nasal congestion, facial pressure, headache, and left eye droopiness. Neurological examination found left ptosis as the only abnormality. Lab results were normal, and COVID-19 PCR was negative. Imaging showed pansinusitis without complications. The patient received IV antibiotics and steroids, followed by oral antibiotics and steroids. Ptosis resolved within 3 days and did not recur at three-month follow-up. Only seven cases of isolated ptosis with rhinosinusitis have been reported, all in males, most recovering with medical therapy alone. This is the first case treated with high-dose steroids in addition to antibiotics. Isolated ptosis may be due to inflammation of the oculomotor nerve's distal branch or related muscular structures. Isolated ptosis in rhinosinusitis has a favorable prognosis. Imaging is crucial to exclude severe complications. The role of steroids needs further evaluation, and the timing for considering surgery remains to be defined.

1 INTRODUCTION

Orbital manifestations of acute sinusitis can range from mild preseptal cellulitis to cavernous sinus thrombosis posing significant risk of vision loss, stroke, or death. These complications typically present with a variety of neuro-ophthalmological symptoms, including pain, fever, vision changes, and restricted eye movements. However, it is exceedingly rare for upper lid ptosis to occur in isolation without any accompanying neuro-ophthalmological findings or other orbital signs, such as proptosis or ophthalmoplegia.1 In this report, we present a unique case of a 30-year-old male who developed unilateral isolated upper lid ptosis in the context of acute rhinosinusitis. This case is particularly noteworthy due to the absence of other symptoms commonly associated with orbital involvement in sinusitis, highlighting the need for careful clinical and radiological evaluation in similar presentations.

2 CASE HISTORY/EXAMINATION

Our case subject is a 30 years old male patient with a history of asthma and bipolar disorder. He admits recent intranasal drug use. He presented to the emergency room for 2 days history of nasal congestion, facial pressure and headache as well as left eye droopiness.

Neurologic exam by a neurologist found the left ptosis to be the only cranial nerve abnormality.

3 DIFFERENTIAL DIAGNOSIS, INVESTIGATIONS, AND TREATMENT

The differential diagnosis included orbital and intracranial complications of rhinosinusitis.

Labs were within normal, WBC = 8.95 k/uL and 71.9% neutrophils.

COVID PCR test was negative.

CT scan of the sinuses showed pansinusitis without orbital complications. MRI showed no evidence of intracranial or orbital extension and normal cavernous sinus (Figure 1). No abnormality seen along the course of the left oculomotor nerve.

Details are in the caption following the image
CT brain bone window showing pansinusitis on axial (A) and coronal (B) cuts. No abnormality is seen at the level of the orbit, extra-ocular muscles and cavernous sinus on T2 (C) and T1 (D) MRI.

The patient was admitted for IV Ampicillin-Sulbactam 3 g once followed by 1.5 g q6h and Dexamethasone 10 mg IV stat followed by 4 mg, one tablet every 6 h.

4 OUTCOME AND FOLLOW-UP

The next day there was improvement in the left ptosis. The patient was discharged on Augmentin 875/125 mg twice daily for 7 days and PO Prednisone 40 mg tapered over 1 week. He received in total during hospitalization four doses of Ampicillin-Sulbactam, one dose of IV Dexamethasone and three tablets of PO Dexamethasone.

Ptosis resolved completely 3 days after the initial presentation. No recurrence or additional symptoms reported on a 3 months follow-up.

5 DISCUSSION

To the best of our knowledge there is only seven cases of isolated ptosis in the setting of imaging confirmed rhinosinusitis. Patient's characteristics and outcome are summarized in Table 1. Interestingly, all of them are males. Six recovered completely within 3–26 days of the onset of ptosis with medical therapy alone (case 1–4; 6–7). Five patients received antibiotics (Case 1,3,4,5, and 7). One did not (case 6) and there is no mention of treatment in one case report (case 2). One patient showed improvement 2 weeks after sinus surgery, it is not clear if the recovery is partial or complete (case 5).

TABLE 1. summary of isolated ptosis cases reported in the English literature.
Case number Authors Year Age/Sex Associated symptoms Imaging AB Treatment Systemic steroids Time to improvement Time to recovery
1 Coker et al.3 1996 15/M Eye pain pansinusitis ceftriaxone None NA 3 days
Erosion of superior wall of MS
Swelling of SR and LPS
2 Arat et al.1 2013 44/M Flu like symptoms Maxillary sinusitis NA None NA 26 days
Eye pain
3 Korkmaz et al.1 2017 27/M NasaL AND PND Ipsilateral pansinusitis Vancomycin None NA 5 days
Eye pain Ipsilateral enhancement of the optic nerve and cavernous sinus Metronidazole
4 Wilbanks et al.1 2018 9/M Nasal congestion Pansinusitis NONE NA 14 days
Eye pain Edema of the superolateral extraconal space of the orbit Amoxicillin clavulanate
Contralateral AOM Enhancement of the orbital bony plate
5 Kim et al.5 2020 15/M Headache Pansinusitis Broad-Spectrum None 14 days NA
6 Larcombe et al.4 2021 64/M Nasal congestion

ipsilateral maxillary, ethmoid and frontal sinusitis

None None NA 7 days
Frontal headache
IPSILateral mydriasis
7 Mirza et al.1 2023 Mid-20s/M Headache

Bilateral ethmoid sinusitis

Ipsilateral maxillary sinusitis

Amoxicillin Clavulanate None NA 3 days
Pungent odor
Recent COVID
  • Abbreviations: AOM, acute otitis media; LPS, levator palpebrae superioris; MS, maxillary sinus; NA, not available; SR, superior rectus.
  • * Complete recovery documented with a photo sent after completion of a 14 days course of Amoxicillin Clavulanate, the specific day on which complete recovery occurred could not be documented.
  • ** 14 days after surgical intervention.

Our case subject is the first in the literature to be treated in addition to antibiotics with high dose steroids. The additional benefit over antibiotics alone is not clear. We believe that the isolated ptosis in the context of rhinosinusitis is secondary to inflammation of the distal branch of the superior division of the oculomotor nerve.1 The latter course in the superior orbital fissure and enters the orbit below the origin of the superior rectus muscle where it measures 1.0 ± 0.34 mm before providing it with 2–6 innervating motor fibers. More distally before innervating the levator palpebrae superioris with 2–4 branches on average, it measures 0.68 ± 0.15 mm.2 The reason for this isolated neurologic deficit remains unclear but one can speculate that low grade inflammation is probably happening in a larger segment of the superior division of the CN3 and the smaller diameter of its distal portion make it more vulnerable. Coker et al. documented inflammation of the Superior Rectus/Levator Palpebrae Superioris complex on imaging offering another potential explanation for the isolated ptosis, that being an isolated muscular instead of neurologic injury.3 It is not clear why the case subject by Mirza et al. was complaining of olfactory dysfunction.1 However, this could be related to the recent COVID infection. Although the ptosis is usually isolated, one case subject developed mydriasis within 24 h. An extensive neurologic work-up showed no abnormalities and the patient recovered completely with only topical intranasal treatment.4

6 CONCLUSION

This case demonstrates an unusual orbital complication of rhinosinusitis. The prognosis of isolated ptosis in this setting seems favorable. It is not clear if recovery is spontaneous or due to antibiotic therapy. The use of steroids needs to be decided on a case-by-case basis since the benefit may not outweigh the harm. It is reasonable to obtain appropriate imaging to rule out cavernous sinus and orbital globe involvement. The time frame between initiation of medical therapy and consideration for surgery when improvement is lacking is yet to be defined.

AUTHOR CONTRIBUTIONS

Youssef El Sayed Ahmad: Conceptualization; data curation; formal analysis; methodology; writing – original draft. Mohammad Abraham Kazemizadeh Gol: Conceptualization; funding acquisition; methodology; resources; supervision; validation; writing – review and editing.

ACKNOWLEDGMENTS

None.

    FUNDING INFORMATION

    The authors received no funding for this work.

    CONFLICT OF INTEREST STATEMENT

    The authors have no conflict of interests to declare.

    CONSENT

    Written informed consent was obtained from the patient to publish this report in accordance with the journal's patient consent policy.

    DATA AVAILABILITY STATEMENT

    Not applicable. All data (of the patient) generated during this study are included in this published article.

      The full text of this article hosted at iucr.org is unavailable due to technical difficulties.